A Japanese global health fund will support the screening of drug libraries owned by five Japanese pharmaceutical companies for new treatments for malaria, tuberculosis and other diseases that affect poor people.
The Japanese Global Health Innovative Technology Fund (GHIT) signed the agreements with national pharmaceutical companies and research institutes, which will carry out the screening, on 30 May.
The Japanese government, a consortium of Japanese pharmaceutical companies and the Bill and Melinda Gates Foundation committed more than US$100 million over a five-year period to the screening.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.